E-Learning

NEW YORK (Reuters) -After closing the books on a banner year for U.S. stocks, investors expect to ride seasonal momentum into mid-January when a slew of economic data and a transition of power in Washington could send markets moving. The S&P 500 rose roughly 25% in 2024 through Dec. 27, while the technology-heavy Nasdaq Composite index <.IXIC >, which surpassed 20,000 for the first time in December, is up over 31%. "There are concerns that maybe the first part of (next) year can involve some repositioning and reallocation of funds and those that are trading today and next week are probably just trying to get a little bit ahead of that," said Robert Pavlik, senior portfolio manager at Dakota Wealth.

Ingles Markets ( (IMKTA) ) has issued an announcement. Ingles Markets announced that it received a notice from Nasdaq due to a delay in filing its Annual Report for the fiscal year ending September 28, 2024. The delay, attributed to the impact of Hurricane Helene, has not affected the immediate Nasdaq listing of its Class A Common Stock. The company has until February 18, 2025, to comply with Nasdaq’s filing requirements or submit a compliance plan. Ingles Markets intends to file the report with

Elite Pharmaceuticals ( (ELTP) ) has issued an update. Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed under the Elite Laboratories, Inc. label, is expected to capture a portion of the $4.3 billion annual sales reported by IQVIA for the original product, potentially enhancing Elite’s market presence in the generic pharmaceutical industry. More about

Investors became gloomy on Friday, threatening to derail a long winning streak for stocks, as inflation remained high.

Wall Street looked to be slogging to the finish of a largely triumphant year.

The Dow Jones Industrial Average fell 0.95%, the S&P 500 was down 1.33% and the Nasdaq Composite briefly was down 1.72%. That’s another reason I think this isn’t causing more apprehension heading into a weekend: it’s not uncommon for the market to hit air pockets when the volumes are light, and it’s been a slow week.

Despite opening the year with a door plug blowout whose fallout reverberated throughout the industry, U.S. airlines had a pretty good year in the stock market. Bloomberg reports that the S&P Supercomposite Airlines index rose 57% this year, beating the S&P 500 by more than 30 percentage points — the biggest such gap in a decade.

Much of the grid was built over 50 years ago, and AI data centers are just one reason energy demand has skyrocketed.

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shares are trading lower on Friday. The firm announced plans to implement a 1-for-20 reverse stock split, which will take effect on December 31. The decision follows authorization from the company's board of directors and majority stockholders. The reverse stock split aims to help the company meet the Nasdaq Capital Market's minimum bid price requirement of $1.00 per share, which is necessary to maintain its listing on the exchange. Also Read: 3

Rail Vision Ltd. (NASDAQ:RVSN) saw its shares rise on Friday after announcing a major achievement in railway safety. The company revealed it had received certification approval for the installation of its MainLine Systems on Israel Railways’ passenger locomotives. This milestone triggers a $300,000 milestone payment and positions Rail Vision for potential future volume procurement from Israel Railways. CEO Shahar Hania emphasized that the certification demonstrates Rail Vision’s commitment to ex